Ichnos’ Early-Stage Myeloma Asset Designed To Avoid ‘Pitfalls’ Of Magrolimab

Glenmark's MD Outlines FY27 Vision

Ichnos Hopes To Draw Partnering Interest For Early Stage Oncology Assets • Source: Shutterstock

More from R&D

More from Scrip